Experts evaluate outcomes for men with low-grade prostate cancer undergoing RP

SAP Partner | <b>UCSF Health</b>

"[Low-grade prostate cancer] is a really interesting field right now," says Kevin Shee, MD, PhD.

In this interview, Kevin Shee, MD, PhD, discusses the background key findings of the Journal of Urology study Gleason Grade 1 Prostate Cancer Volume at Biopsy Is Associated With Upgrading but Not Adverse Pathology or Recurrence After Radical Prostatectomy: Results From a Large Institutional Cohort. Shee is a urology resident at the University of California, San Francisco.